SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-022174
Filing Date
2021-09-08
Accepted
2021-09-08 08:30:58
Documents
36
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 329119
2 ex31-1.htm EX-31.1 11212
3 ex32-1.htm EX-32.1 4273
  Complete submission text file 0001493152-21-022174.txt   1249626

Data Files

Seq Description Document Type Size
4 INLINE XBRL INSTANCE DOCUMENT lwel-20201231.xml EX-101.INS 112185
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lwel-20201231.xsd EX-101.SCH 14780
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lwel-20201231_cal.xml EX-101.CAL 20744
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lwel-20201231_def.xml EX-101.DEF 49468
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lwel-20201231_lab.xml EX-101.LAB 97062
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lwel-20201231_pre.xml EX-101.PRE 88112
Mailing Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140 1 617 430 5222
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-187874 | Film No.: 211240795
SIC: 2834 Pharmaceutical Preparations